Kenya will begin producing Covid-19 vaccines locally next year in collaboration with unnamed pharmaceutical companies to alleviate supply bottlenecks that have derailed mass vaccination.
Health Cabinet Secretary Mutahi Kagwe announced in an internal. known vaccine plan that the country has started construction of a filling plant for the Covid-19 vaccines.
A full-fledged vaccine production plant is to be built by 2024, said Mr Kagwe. A filling and processing plant helps third parties to fill, seal and package the vaccine from the main manufacturers in vials or syringes for distribution.
Many manufacturers use third parties to fill and complete their vaccines and in African countries Countries such as Senegal, Rwanda and South Africa are holding talks with investors to start producing coronavirus vaccines.
“In order to improve our security of supply with vaccines, the government has ordered the local production of Covid-19- Vaccines started setting up a fill-and-finish facility through strategic partnerships and technology transfer, “said Mr. Kagwe in the National Covid-19 Vaccine Deployment Plan 2021.
” We want to start local production of in the first quarter 2022 and have full human vaccine production capacity by 2024. “
Mr Kagwe said local production will help ensure adequate vaccines to secure substances to promote nationwide vaccination programs.
Kenya plans to vaccinate 26 milli on adult Kenyans by the end of June next year and at least 10 million by Christmas this year.
It has vaccine doses of Pfizer and Johnson and Johnson acquired to complement Astrazeneca vaccines.
Kenya would need to partner with a vaccine patent holder to manufacture Covid-19 vaccines.